Skip to main content

Advertisement

Log in

In vivo markers of Parkinson’s disease and dementia with Lewy bodies: current value of the 5G4 α-synuclein antibody

  • Correspondence
  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Kovacs GG, Wagner U, Dumont B et al (2012) An antibody with high reactivity for disease-associated α-synuclein reveals extensive brain pathology. Acta Neuropathol 124:37–50. doi:10.1007/s00401-012-0964-x

    Article  CAS  PubMed  Google Scholar 

  2. Laske C, Fallgatter AJ, Stransky E et al (2011) Decreased α-synuclein serum levels in patients with Lewy body dementia compared to Alzheimer’s disease patients and control subjects. Dement Geriatr Cogn Disord 31:413–416. doi:10.1159/000329763

    Article  CAS  PubMed  Google Scholar 

  3. Malek N, Swallow D, Grosset KA et al (2014) Alpha-synuclein in peripheral tissues and body fluids as a biomarker for Parkinson’s disease—a systematic review. Acta Neurol Scand. doi:10.1111/ane.12247

    Google Scholar 

  4. Mollenhauer B, Locascio JJ, Schulz-Schaeffer W et al (2011) α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study. Lancet Neurol 10:230–240. doi:10.1016/S1474-4422(11)70014-X

    Article  CAS  PubMed  Google Scholar 

  5. Parnetti L, Castrioto A, Chiasserini D et al (2013) Cerebrospinal fluid biomarkers in Parkinson disease. Nat Rev Neurol 9:131–140. doi:10.1038/nrneurol.2013.10

    Article  CAS  PubMed  Google Scholar 

  6. Shi M, Zabetian CP, Hancock AM et al (2010) Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson’s disease. Neurosci Lett 480:78–82. doi:10.1016/j.neulet.2010.06.009

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  7. Unterberger U, Lachmann I, Voigtländer T et al (2014) Detection of disease-associated α-synuclein in the cerebrospinal fluid: a feasibility study. Clin Neuropathol 33:329–334

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgments

We thank Ron Postuma for comments to the manuscript. The study has been partly supported by the BIOMARKAPD project (JPND Research). Samples were obtained from the Neuro-Biobank of the University of Tuebingen, Germany (http://www.hih-tuebingen.de/core-facilities/biobank/for-researchers/). This biobank is supported by the local University, the Hertie Institute and the DZNE.

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Walter Maetzler.

Additional information

W. Maetzler, A. Pilotto and A. Apel equally contributed to this work.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 269 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Maetzler, W., Pilotto, A., Apel, A. et al. In vivo markers of Parkinson’s disease and dementia with Lewy bodies: current value of the 5G4 α-synuclein antibody. Acta Neuropathol 128, 893–895 (2014). https://doi.org/10.1007/s00401-014-1364-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00401-014-1364-1

Keywords

Navigation